Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group.
about
Radioiodine therapy versus antithyroid medications for Graves' diseaseRadioiodine treatment for pediatric Graves' diseasePediatric Graves' disease: management in the post-propylthiouracil EraExposing the thyroid to radiation: a review of its current extent, risks, and implicationsNovel approach to analyzing the carcinogenic effect of ionizing radiations.Current and emerging treatment options for Graves' hyperthyroidism.Non-surgical approach to the benign nodular goiter: new opportunities by recombinant human TSH-stimulated 131I-therapy.Radiation and breast carcinogenesis.Graves' disease, thyroid nodules and thyroid cancer.Diagnosis and management of Graves' disease.Failure of radioactive iodine in the treatment of hyperthyroidism.Systemic oxidative stress to nucleic acids is unaltered following radioiodine therapy of patients with benign nodular goiterPrediction of post-treatment hypothyroidism using changes in thyroid volume after radioactive iodine therapy in adolescent patients with Graves' disease.Juvenile thyrotoxicosis; can we do better?Radioiodine I-131 for the therapy of graves' disease.Comparison of internal dosimetry factors for three classes of adult computational phantoms with emphasis on I-131 in the thyroid.Chemical genoprotection: reducing biological damage to as low as reasonably achievable levels.S values for 131I based on the ICRP adult voxel phantoms.Long-term risks for thyroid cancer and other neoplasms after exposure to radiation.The treatment of Graves' disease in children.The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy.Second primary malignancies in thyroid cancer patients.Pediatric thyroid disease: when is surgery necessary, and who should be operating on our children?A large cohort study of hypothyroidism and hyperthyroidism in relation to gynecologic cancersRadioactive iodine (131I) therapy for differentiated thyroid cancer in Japan: current issues with historical review and future perspective.Diagnosis and management of Graves disease: a global overview.Controversies in the management of Graves' disease in children.Hyperthyroidism, Hypothyroidism, and Cause-Specific Mortality in a Large Cohort of Women.Effects of radioiodine administration on serum concentrations of matrix metalloproteinases, adiponectin and thrombospondin-1.In contrast to matrix metalloproteinases, serum adiponectin concentrations increase after radioiodine treatment of thyrotoxicosis.What to tell patients about radioiodine therapy.Unsuccessful radioiodine treatment of a non-toxic goiter: a case report.Radiometabolic treatment of hyperthyroidism with a calculated dose of 131-iodine: results of one-year follow-up.Radioiodine treatment for benign thyroid disorders: results of a nationwide survey of UK endocrinologists.All-cause and cardiovascular mortality risk after surgery versus radioiodine treatment for hyperthyroidism.Thyroid cancer after exposure to radioactive 131I.Radioiodine treatment for benign thyroid diseases.2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism
P2860
Q24186122-5C8A5E8B-1934-4E65-B159-FCAC96D4BB1CQ24242649-7630C153-253C-4304-A53C-F58A7AA99A04Q26864019-12EB58C2-B63F-45E3-9985-6BB03222E864Q28385131-79C69DFF-11C1-42DB-A1DF-D43ADCBDBA43Q30353435-5C86ED4F-BF25-4F37-8507-BB71C8893894Q33635029-22844F1C-A844-4CEB-9214-1A925E063A3DQ34040067-EDB4ECB2-4CC5-45F1-8EF6-83E0B18BE92AQ34243494-E124E7DC-F14B-4736-91D8-B7BAF024EA68Q34564546-B3FB2C74-1F99-4849-9065-0F0177EC1AA4Q34733591-F0C0259F-AEC9-4904-8345-3B34C63F1819Q35088255-0F32EDF4-E34F-425C-921B-99D1DA41097AQ35507233-1ADB5770-593B-44A2-9486-3FD6DDF78B34Q35559999-94FC1485-BB37-46DE-8C05-99EBC7162238Q35842892-1F6D436F-89DF-4016-960B-7C7F9686B845Q35911969-EC8E1CBD-4265-43F9-B338-63505DDA317EQ36359352-975E7176-99B9-4501-9C37-2DB0D6B91735Q36461281-3D6AB98D-D718-495D-BD48-CA3753B94D69Q36509422-AF6C6E25-FC84-4E81-940F-F093DF0971AEQ36575440-C5851456-E411-4DD1-86DF-A98406F5431AQ36665085-D6622289-EB2A-461B-AAD9-4E3B16D5A93FQ36666417-05B0DCAE-780B-4AB0-85EB-35416237FE28Q36671533-0302930A-0363-4D7A-AFEE-F4030E820950Q36715865-E33EA4A1-F646-48AE-81B6-AE3759EA163FQ37057772-61AB91B4-E46A-4468-9938-2E47F6A3F1B4Q37955829-CC449201-C14F-4B19-A345-6736EE30D9A1Q38152621-8E758EE3-AADB-4C5C-8CB5-31B0F130334FQ38827752-8E3CBD7B-BB36-4090-90C1-FAFB543D8813Q40173864-8E2AB3DD-7791-43DE-B2BC-04C5EA244375Q41820261-374924BA-ECEA-4793-8FD0-A62E4EBB07A4Q42420408-632BB0B9-8A75-49E0-8440-586B09119115Q42422425-7167F320-9E42-4FF9-A94C-CF6089FEA703Q45067437-B5BE395B-04FE-47A7-8D9B-4B89EEC2F848Q46027362-50143CAB-5E58-4165-BDAF-3130F60D39CAQ46921358-9DAF2677-1C93-4E01-883D-30016C15B092Q48342372-3E53E806-65B9-435E-B790-8A1944ED9794Q53217052-26C42E98-85C5-47B3-B3E0-B9F8267D2B1DQ53334064-0E6426F9-C7FD-4AE4-8C48-8A42AB85A6A8Q57136607-A02853E8-4425-45E1-8A8E-66DD95615E89
P2860
Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
name
Cancer mortality following tre ...... Therapy Follow-up Study Group.
@ast
Cancer mortality following tre ...... Therapy Follow-up Study Group.
@en
Cancer mortality following tre ...... Therapy Follow-up Study Group.
@nl
type
label
Cancer mortality following tre ...... Therapy Follow-up Study Group.
@ast
Cancer mortality following tre ...... Therapy Follow-up Study Group.
@en
Cancer mortality following tre ...... Therapy Follow-up Study Group.
@nl
prefLabel
Cancer mortality following tre ...... Therapy Follow-up Study Group.
@ast
Cancer mortality following tre ...... Therapy Follow-up Study Group.
@en
Cancer mortality following tre ...... Therapy Follow-up Study Group.
@nl
P2093
P356
P1476
Cancer mortality following tre ...... Therapy Follow-up Study Group.
@en
P2093
B S Harris
D A Hoffman
D V Becker
M B Goldman
M E Warshauer
P304
P356
10.1001/JAMA.280.4.347
P407
P50
P577
1998-07-01T00:00:00Z